Cytokine production of CD8+ immune T cells but not of CD4 + T cells from Toxoplasma gondii-infected mice is polarized to a type 1 response following stimulation with tachyzoite-infected macrophages

Journal of Interferon and Cytokine Research

Volumn 26, Issue 11, 2006, Pages 787-792

  Miller, Renee ^a   Wen, Xiangshu ^a   Dunford, Bradley ^a   Wang, Xisheng ^a   Suzuki, Yasuhiro ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LYSATE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNOSTIMULATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; FEMALE; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; TH1 CELLS; TOXOPLASMA; TOXOPLASMOSIS;

TOXOPLASMA GONDII;

EID: 33751103431     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2006.26.787     Document Type: Article

References (42)

1. Suzuki Y. Immunopathogenesis of cerebral toxoplasmosis. J. Infect. Dis. 2002;186 (Suppl 2):S234-240.
2. Yap GS, Sher A. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiology 1999;201:240-247.
3. Suzuki Y, Orellana MA, Schreiber RD, Remington JS. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 1988;240:516-518.
4. Frenkel JK. Adoptive immunity to intracellular infection. J. Immunol. 1967;98:1309-1319.
5. + T cells in mice. J. Immunol. 1988;140:3943-3946.
6. + immune T cells against toxoplasmosis in mice. J. Immunol. 1990;144:1954-1956.
7. + T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 1991;146:286-292.
8. Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, Caspar P, Trinchieri G, Sher A. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 1994;153:2533-2543.
9. Suzuki Y, Yang Q, Yang S, Nguyen N, Lim S, Liesenfeld O, Kojima T, Remington JS. IL-4 is protective against development of toxoplasmic encephalitis. J. Immunol. 1996;157:2564-2569.
10. Roberts CW, Ferguson DJ, Jebbari H, Satoskar A, Bluethmann H, Alexander J. Different roles for interleukin-4 during the course of Toxoplasma gondii infection. Infect Immun. 1996;64:897-904.
11. Chardes T, Velge-Roussel F, Mevelec P, Mevelec MN, Buzoni-Gatel D, Bout D. Mucosal and systemic cellular immune responses induced by Toxoplasma gondii antigens in cyst orally infected mice. Immunology 1993;78:421-429.
12. Sibley LD, Boothroyd JC. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 1992;359:82-85.
13. Howe DK, Sibley LD. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J. Infect. Dis. 1995;172:1561-1566.
14. Rodgers L, Wang X, Wen X, Dunford B, Miller R, Suzuki Y. Strains of Toxoplasma gondii used for tachyzoite antigens to stimulate spleen cells of infected mice in vitro affect cytokine responses of the cells in the culture. Parasitol. Res. 2005;97:332-335.
15. Grigg ME, Bonnefoy S, Hehl AB, Suzuki Y, Boothroyd JC. Success and virulence in Toxoplasma as the result of sexual recombination between two distinct ancestries. Science 2001;294:161-165.
16. Kang H, Suzuki Y. Requirement of non-T cells that produce gamma interferon for prevention of reactivation of Toxoplasma gondii infection in the brain. Infect. Immun. 2001;69:2920-2927.
17. + T cells prevent development of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease. J. Immunol. 2003;170:4254-4259.
18. Wang X, Rang H, Kikuchi T, Suzuki Y. Gamma interferon production, but not perforin-mediated cytolytic activity, of T cells is required for prevention of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease. Infect. Immun. 2004;72:4432-4438.
19. Mayer KD, Mohrs K, Crowe SR, Johnson LL, Rhyne P, Woodland DL, Mohrs M. The functional heterogeneity of type 1 effector T cells in response to infection is related to the potential for IFN-gamma production. J. Immunol 2005;174:7732-7739.
20. Gaffen SL, Liu KD. Overview of interleukin-2 function, production and clinical applications. Cytokine 2004;28:109-123.
21. + T cell clones isolated from NOD mice. J. Immunol. Methods 1999;228:87-95.
22. + T cells in chronic plaque psoriasis are Tc1 cells producing heterogeneous levels of interferon-gamma. Exp. Dermatol. 2001;10:168-174.
23. + precursors of cytotoxic T lymphocytes. Eur. J. Immunol. 1987;17:229-236.
24. Widmer MB, Bach FH. Antigen-driven helper cell-independent cloned cytolytic T lymphocytes. Nature 1981;294:750-752.
25. Roopenian DC, Widmer MB, Orosz CG, Bach FH. Helper cell-independent cytolytic T lymphocytes specific for a minor histocompatibility antigen. J. Immunol 1983;130:542-545.
26. + cytotoxic T lymphocytes express IL-1 receptors and require IL-1 for secretion of IL-2. J. Immunol. 1989;142:2187-2191.
27. Musso T, Gusella GL, Brooks A, Longo DL, Varesio L. Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes. Blood 1994;83:1408-1411.
28. Nagineni CN, Pardhasaradhi K, Martins MC, Detrick B, Hooks JJ. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infect. Immun. 1996;64:4188-4196.
29. Pfefferkorn ER. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. USA 1984;81:908-912.
30. Daubener W, Spors B, Hucke C, Adam R, Stins M, Kim KS, Schroten H. Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase. Infect. Immun. 2001;69:6527-6531.
31. Dimier IH, Woodman JP, Bout DT. Human endothelial cells activated by Interferon gamma, by interleukin-1 and TNF inhibit the replication of Toxoplasma gondii. Ann. Rech. Vet. 1992;23:329-330.
32. Gazzinelli RT, Oswald IP, James SL, Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J. Immunol. 1992;148:1792-1796.
33. Swierczynski B, Bessieres MH, Cassaing S, Guy S, Oswald I, Seguela JP, Pipy B. Inhibitory activity of anti-interleukin-4 and anti-interleukin-10 antibodies on Toxoplasma gondii proliferation in mouse peritoneal macrophages cocultured with splenocytes from infected mice. Parasitol. Res. 2000;86:151-157.
34. Suzuki Y, Sher A, Yap G, Park D, Neyer LE, Liesenfeld O, Fort M, Kang H, Gufwoli E. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J. Immunol. 2000;164:5375-5382.
35. + T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α. J. Immunol. 1996;157:798-805.
36. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
37. + T cells in the control of inflammation. J. Immunol. 2003;171:5018-5026.
38. Rabin EM, Ohara J, Paul WE. B-cell stimulatory factor 1 activates resting B cells. Proc. Natl. Acad. Sci. USA 1985;82:2935-2939.
39. Oliver K, Noelle RJ, Uhr JW, Krammer PH, Vitetta ES. B-cell growth factor (B-cell growth factor I or B-cell-stimulating factor, provisional 1) is a differentiation factor for resting B cells and may not induce cell growth. Proc. Natl. Acad. Sci. USA 1985;82:2465-2467.
40. Kang H, Remington JS, Suzuki Y. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-γ, TNF-α, and inducible nitric oxide synthase. J. Immunol. 2000;164:2629-2634.
41. Sayles PC, Gibson GW, Johnson LL. B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii. Infect. Immun. 2000;68:1026-1033.
42. O'Garra A, Murphy K. Role of cytokines in development of Th1 and Th2 cells. Chem. Immunol. 1996;63:1-13.